Candida sp infections in intensive care: A survey on French practices;Infections à Candida sp en réanimation: Enquête sur les pratiques françaises

Presse Medicale

Volumn 32, Issue 10, 2003, Pages 440-449

  Gauzit, Rémy ^a   Cohen, Y ^b   Dupont, H ^c   Hennequin, C ^d   Montravers, P ^a   Timsit, J F ^c   Veber, B ^e   Chevalier, E ^f   Blin, P ^f   Palestros, B ^g  

^a HÔPITAL JEAN VERDIER   (France)

^b AVICENNE HOSPITAL   (France)

^c BICHAT HOSPITAL   (France)

^d INSTITUT PASTEUR   (France)

^e HÔPITAL CHARLES NICOLLE   (France)

^f Societe Icare   (France)

^g PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE;

ARTICLE; BACTERIAL COLONIZATION; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDIASIS; CATHETER INFECTION; CATHETERIZATION; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG SENSITIVITY; FRANCE; FUNGUS ISOLATION; HEALTH SERVICE; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; NONHUMAN; PRACTICE GUIDELINE; PRESCRIPTION; QUESTIONNAIRE;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CROSS INFECTION; CROSS-SECTIONAL STUDIES; EQUIPMENT CONTAMINATION; FEMALE; FLUCONAZOLE; FRANCE; FUNGEMIA; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; ITRACONAZOLE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RISK FACTORS;

EID: 0344837369     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Pfaller MA, Diekema DJ, Jones RN et al and the SENTRY participant group. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravoconazole and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobiam surveillance programm. J Clin Microbiol 2001; 39: 3 254-9.
2. Vincent JL, Bihari DJ, Suter PM et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA 1995; 274: 639-44.
3. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999; 27: 887-92.
4. Rangel-Frausto MS, Wiblin T, Blumberg HM et al. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999; 29: 253-8.
5. Edmond MB, Wallace SE, Mc Clish DK, Pfaller MA, Jones RN, Wenzel P. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999; 29: 239-244.
6. Levy I, Rubin LG, Vasishtha S, Tucci V, Sood SK. Emergence of Candida parapsilosis as the predominent species causing candidemia in children. Clin Infect Dis 1998; 26: 1086-8.
7. Voss A, le Noble JLML, Lunel FMV, Foudraine NA, Meis JFGM. Candidemia in intensive care unit patients: risk factors for mortality. Infection 1997; 25: 8-11.
8. Wey SB, Mari M, Pfaller MA, Woolson RF, Wenzel RP. Hospit-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988; 148: 2642-5.
9. Nolla-Salas J, Sitges-Serra A, Leon-Gil C et al. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Med 1997; 23: 23-30.
10. Voss A, Hollis RJ, Pfaller MA, Wenzel RP, Doebbeling BN. Investigation on the sequence of colonization and candidemia in non-neutropenic patients. J Clin Microbiol 1994; 32: 975-80.
11. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220: 751-8.
12. Pittet D, Anaissie E, Solomkin J.-S. When to start antifungal therapy in the non-neutropenic critically ill? In: Vincent JI, Ed. Yearbook of Intensive Care and emergency Medicine. Bruxelles: Springer; 1996. p. 567-77.
13. Vincent JL, Anaissie E, Bruining H et al. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 1998; 24: 206-16.
14. Rex JH, Walsh TJ; Sobel JD et al. Practice guideline for the treatment of candidiasis. Clin Infect Dis 2000; 30: 662-78.
15. Edwards JE, Bodey GP, Bowden RA et al. International conference for the developpement of a consensus on the management and prevention of severe Candida infections. Clin Infect Dis. 1997; 25: 43-59.
16. Petri MG, Konig J, Moecke HP et al. Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Intensive Care Med 1997; 23: 317-25.
17. Weis C, Kappe R, Sonntag HG. Western blot analysis of the immune response to Candida albicans antigens in 391 long-term intensive care patients. Mycoses 1997; 40: 153-7.
18. Reiss E, Morrison C. Nonculture methods for diagnosis of disseminated candidiasis. Clin Microbiol Rev 1993; 6: 311-23.
19. Martino P, Gumenia C Vendeti M, et al. Candida colonization and systemic infection in neutropenic patients. A retrospective study. Cancer 1989; 62: 2030-4.
20. Solomkin JS, Flohr AB, Quie PG, Simmons RL. The role of Candida in intraperitoneal infections. Surgery 1980; 88: 524-30.
21. Wey SB, Mori M, Pfaller MA, Woolson RF. Wenzel RR Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 1989; 149: 2349-53.
22. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992; 15: 414-21.
23. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24:1122-8.
24. Anaissie EJ, Rex JH, Uzun O, Vartivarian S. Predictors of adverse outcome in patients with candidemia. Am J Med 1998; 104: 238-45.
25. Nguyen MH, Peacock JE, Tanner DC, Morris AJ, Nguyen ML, Snydman DR, Therapeutic approaches in patients with candidemia: evaluation in a multicenter, prospective, observational study. Arch Intern Med 1995; 155: 2429-35.
26. Rex JH, Bennett JE, Sugar AM et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994: 331: 1325-30.
27. El-Ebiary M, Torres A, Fabregas N et al. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate post mortem histologic study. Am J Respir Crit Care Med 1997; 156: 583-90.
28. Rello J, Esandi ME, Diaz E, Mariscal D, Gallego M, Valles M. The role of Candida sp isolated from bronchoscopic samples in non-neutropenic patients. Chest 1998; 114: 146-9.
29. Conférence de consensus: prise en charge des péritonites communautaires. Ann Fr Anesth Reanim 2001; 20: Suppl 2: 350-67.
30. Dupont H, Gauzit R, Montravers P, Veber B, Blin P, Esnault Y. Pathogenic role of Candida in postoperative peritonitis. (Abstract 222). IDSA, San Francisco, 2001.
31. Kauffmann CA, Vasquez JA, Sobel JD et al. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 2000; 30: 14-18.
32. Sobel JD, Kauffmann CA, McKinsey D et al. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 2000; 30:19-24.
33. Cohen J, Denning DW, Evans EGV and the British Society for Antimicrobial Chemotherapy Working Party. Management of deep Candida infection in surgical and intensive care unit patients. Intensive Care Med 1994; 20: 522-8.
34. Sobel J.-D. Management of infections caused by Candida glabrata. Current Infectious Disease Reports 2000; 2: 424-8.